Loading…
Evonik submitted a binding offer on October 27, 2016 for METEX's entire methionine technology platform. The METEX board agreed on November 3 to consider the offer and begin a consultation with its Workers Council, which may take 15 to 60 days.
The technology covers patents, essential bacteria strains and the inoLa brand.
The pending deal could bring fermentation-based methionine into Evonik's portfolio, which may add competitive supply over time. The consultation period means no immediate price effect.
business-standard.comBS B2B BureauNov 15, 2016Not enough comparable past events yet for a historical read.
Moves of each commodity's benchmark from the last close before the event. Historical reads pool past events of the same kind; they describe what happened, not what will. Not investment advice.
